Global Butorphanol Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Butorphanol Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Butorphanol is a morphinan-type synthetic agonist–antagonist opioid analgesic developed by Bristol-Myers. Butorphanol is available as the tartrate salt in injectable, tablet, and intranasal spray formulations. The tablet form is only used in dogs, cats and horses due to low bioavailability in humans.
Butorphanol report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Butorphanol market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Human and Veterinary are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Butorphanol industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Butorphanol key manufacturers include Hikma Pharmaceuticals, Athanas Enterprise Private Limited, Pfizer, Apothecon Pharmaceuticals, Mylan, Novex Pharma, Bristol Myers Squibb, Sanochemia Pharmazeutika and Selectavet, etc. Hikma Pharmaceuticals, Athanas Enterprise Private Limited, Pfizer are top 3 players and held % sales share in total in 2022.
Butorphanol can be divided into Spray, Injection and Tablet,, etc. Spray is the mainstream product in the market, accounting for % sales share globally in 2022.
Butorphanol is widely used in various fields, such as Human and Veterinary, etc. Human provides greatest supports to the Butorphanol industry development. In 2022, global % sales of Butorphanol went into Human filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Butorphanol market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Hikma Pharmaceuticals
Athanas Enterprise Private Limited
Pfizer
Apothecon Pharmaceuticals
Mylan
Novex Pharma
Bristol Myers Squibb
Sanochemia Pharmazeutika
Selectavet
Richter Pharma Ag
Troy Laboratories Nz
Animedica
Boehringer Ingelheim Santé Animale
Ausrichter
Zoetis
Dechra Pharmaceuticals
Faunapharma
Merck KGaA
Segment by Type
Spray
Injection
Tablet
Human
Veterinary
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Butorphanol market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Butorphanol, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Butorphanol industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Butorphanol in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Butorphanol introduction, etc. Butorphanol Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Butorphanol market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Butorphanol report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Butorphanol market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Human and Veterinary are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Butorphanol industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Butorphanol key manufacturers include Hikma Pharmaceuticals, Athanas Enterprise Private Limited, Pfizer, Apothecon Pharmaceuticals, Mylan, Novex Pharma, Bristol Myers Squibb, Sanochemia Pharmazeutika and Selectavet, etc. Hikma Pharmaceuticals, Athanas Enterprise Private Limited, Pfizer are top 3 players and held % sales share in total in 2022.
Butorphanol can be divided into Spray, Injection and Tablet,, etc. Spray is the mainstream product in the market, accounting for % sales share globally in 2022.
Butorphanol is widely used in various fields, such as Human and Veterinary, etc. Human provides greatest supports to the Butorphanol industry development. In 2022, global % sales of Butorphanol went into Human filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Butorphanol market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Hikma Pharmaceuticals
Athanas Enterprise Private Limited
Pfizer
Apothecon Pharmaceuticals
Mylan
Novex Pharma
Bristol Myers Squibb
Sanochemia Pharmazeutika
Selectavet
Richter Pharma Ag
Troy Laboratories Nz
Animedica
Boehringer Ingelheim Santé Animale
Ausrichter
Zoetis
Dechra Pharmaceuticals
Faunapharma
Merck KGaA
Segment by Type
Spray
Injection
Tablet
Segment by Application
Human
Veterinary
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Butorphanol market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Butorphanol, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Butorphanol industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Butorphanol in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Butorphanol introduction, etc. Butorphanol Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Butorphanol market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.